Venture Capital in Germany - Deal Term Questionnaire 2017

14 Aug 2017 | 02:48 pm |

Pinsent Masons is conducting a survey to determine the frequency and practice of contractual provisions agreed on in venture capital financing for young German technology companies.

It only takes approximately 5-8 minutes to answer and your feedback will contribute to the findings of a report due to be published in autumn 2017. 

Please complete our online survey. Please click here to access.  

Alternatively, you may also download the questionnaire here. Returns can be made by post to Pinsent Masons Germany LLP, Venture Capital & Private Equity, Ottostr. 21, 80333 Munich/Germany, or by fax to +49 89 203043 501 or by email to [email protected]

Pinsent Masons Germany Venture Capital & Private Equity Team is recognised as one of the leading venture capital and private equity practices. It is dedicated and focused on helping successful mid-market institutions deliver their ambitions. 

If you would like to receive a free copy of the report, please send us your contact details and a notification to: vc‑[email protected]

We thank you in advance for your support.

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts